The Formula Behind 7× Greater Financial Impact: How technology-powered pre-bill reviews, guided by physician expertise, uncover more clinically supported revenue opportunities.

AI Can Find Revenue. But Can It Defend It?

AI can surface potential revenue opportunities at scale—but identifying an alert is not the same as validating a clinically defensible outcome.

In this webinar, Enjoin will examine the results of a 51-encounter review conducted after an AI-based solution. Enjoin physician reviews identified $553,000 in financial impact, compared with $78,000 originally attributed to AI. More than half of the AI alerts also fell within DRG families that Enjoin physicians had already identified, highlighting the difference between generating alerts and uncovering meaningful, defensible opportunities.

The health system ultimately reported a 671% ROI above AI-only approaches, through a physician-led, governance-driven approach.

Attendees will learn why the strongest model is not anti-AI, but technology-enabled and clinically led—combining broad analysis with deep physician review to improve revenue accuracy and withstand payer scrutiny.